Skip to main content
AVANOS MEDICAL, INC. logo

AVANOS MEDICAL, INC. — Investor Relations & Filings

Ticker · AVNS ISIN · US40650V1008 LEI · 549300YCXWOM7NEWMQ58 US Manufacturing
Open in API
Filings indexed 673 across all filing types
Latest filing 2026-06-01 Regulatory Filings
Country US United States of America
Listing US AVNS

About AVANOS MEDICAL, INC.

https://avanos.com/

Avanos Medical, Inc. is a medical technology company that develops, manufactures, and markets medical device solutions. The company's portfolio is focused on two primary segments: Pain Management & Recovery and Enteral Feeding. The Pain Management & Recovery division provides a range of non-opioid therapies and solutions for managing chronic and post-surgical pain, targeting specialties such as anesthesiology, orthopedics, and interventional pain management. The Enteral Feeding division offers a comprehensive portfolio of nutrition delivery systems and products for a wide spectrum of patients, from neonates and pediatrics to adults, supporting healthcare providers in critical and long-term care settings. The company is focused on delivering clinically superior solutions that improve patient outcomes and facilitate recovery.

Recent filings

Filing Released Lang Actions
FORM SD
Regulatory Filings Classification · 94% confidence The document is an SEC Specialized Disclosure Report on Form SD filed under Rule 13p-1 for conflict minerals. It contains the actual Form SD disclosure (Items 1.01 and 1.02), exhibit references, and a signature block. This is a compliance/regulatory filing rather than an annual report, earnings release, or other categories. It falls under the general regulatory filings fallback.
2026-06-01 English
10-Q - AVANOS MEDICAL, INC. (0001606498) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-05 English
8-K - AVANOS MEDICAL, INC. (0001606498) (Filer)
Regulatory Filings Classification · 85% confidence The document is an SEC Form 8-K “Current Report” (a regulatory filing) reporting Item 2.02 Results of Operations and Financial Condition and furnishing a press release as an exhibit. It contains no substantive financial statements or detailed earnings data itself, serving instead as a compliance filing under the Securities Exchange Act. This falls under the general “Regulatory Filings” category.
2026-05-05 English
8-K - AVANOS MEDICAL, INC. (0001606498) (Filer)
M&A Activity Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated April 13, 2026, by Avanos Medical, Inc. The content describes the entry into a Material Definitive Agreement, specifically a Merger Agreement involving the company and a parent entity. It details the terms of the merger, conditions, board approvals, stockholder voting requirements, termination rights, and financing commitments. The document also mentions that upon consummation of the merger, the company's stock will be delisted from the NYSE. The filing is a current report disclosing a significant corporate transaction (merger) and related agreements, which aligns with announcements related to merger and acquisition activity. It is not a full annual or quarterly report, nor an earnings release or proxy statement. The detailed description of the merger agreement and related terms fits the category of M&A Activity filings, which cover announcements and documents related to merger proposals or takeover bids. Therefore, the appropriate classification is TAR (M&A Activity). The document length (15,000 characters) and detailed content support a high confidence in this classification.
2026-04-14 English
SCHEDULE 13G/A - AVANOS MEDICAL, INC. (0001606498) (Subject)
Major Shareholding Notification
2026-03-26 English
4 - AVANOS MEDICAL, INC. (0001606498) (Issuer)
Director's Dealing
2026-03-17 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.